CTKB NASDAQ
Cytek Biosciences, Inc.
1W: +3.9%
1M: +25.2%
3M: +27.1%
YTD: +19.3%
1Y: +62.6%
3Y: -5.0%
5Y: -75.7%
$5.87
+0.06 (+1.03%)
Weekly Expected Move ±6.4%
$5
$5
$6
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$207M
Revenue
+5.4% YoY
$-81M
Net Income
-1158.8% YoY
$-12M
Free Cash Flow
-209.2% YoY
58.9%
Gross Margin
-23.7%
Op. Margin
-25.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-23.0%
ROA-17.1%
ROIC-40.8%
Valuation
P/E-9.4
P/B2.4
EV/EBITDA-12.4
Leverage
Debt/Equity0.08
Current Ratio4.48
Interest Cov.-22.2x
Quality Scores
Piotroski F3/9
Altman Z3.30
Beneish M-3.64